“The Survival Rate Comparison of Non Small Cell Lung Carcinoma Patients Who Are Given by Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor and Those Given by First-Line Chemotherapy Treatment”. Nusantara Medical Science Journal 6, no. 2 (January 20, 2022): 103–115. Accessed August 7, 2026. https://journal-598.unhas.ac.id/index.php/jmednus/article/view/18857.